Well, I certainly did not expect to see this today… Mark Cuban testifying to Congress about the state of prescription drugs in the U.S. and not only announcing that his company, Cost Plus Drugs will integrate with TrumpRx but offering high praise for TrumpRx: “We’ll work with TrumpRx. I mean, it’s incredible. It’s stupendous. It’s like the most incredible program ever. We’re excited to offer them our API so when prices go down, everybody benefits.” Now I’m not going to sit here and tell you I think these two guys are now best buddies….clearly not. I also assume that Mark Cuban was perhaps purposely going over the top to be maybe even a bit sarcastic. And yes, he clearly has a vested interest in partnering up to make his own business more successful. I get all of that. I’m not wearing rose-colored glasses. But setting all of that aside for a minute, I am going to take a moment and just appreciate the nice comments at face value: MARK CUBAN’S DRUG COMPANY PARTNERS WITH TRUMPRX Mark Cuban just announced Cost Plus Drugs will integrate with TrumpRx, Trump’s new drug price transparency platform, to give Americans real-time access to the lowest medication prices: “We’ll work with TrumpRx. I mean,… https://t.co/e2WNBKY57z pic.twitter.com/Isbmifn3HT — Mario Nawfal (@MarioNawfal) October 22, 2025 And yes, the clip is real and not AI, which is something you have to always check these days. Here is the full clip from C-SPAN: Chairman: Thank you, Chairman. Uh, thanks to all of you for being here today and talking about a subject that’s very important to all Americans across the country — and as Dr. Smith said, an out-of-control health care system, which it is. Mr. Cuban, innovative companies like Cost Plus Drugs have already proven that bypassing traditional PBMs can deliver real savings at pharmacy counters. President Trump has announced Trump RX, a new website to connect patients directly with the best prices. How might Trump RX and direct patient programs improve affordability for patients? Your basic — why you’re doing this? Mark Cuban: Yeah, I mean, we’ll work with Trump RX. I mean, it’s incredible. It’s stupendous. It’s like the most incredible program ever. And so, we’re excited to offer them our API so that they’ll be able to download our daily prices so when they go down, everybody benefits. Plus, I like what they’re doing with the MFNs because, as I mentioned in my comments, our brand drugs are more expensive because PBMs are involved. And with Trump RX and the MFN program, that allows manufacturers to work around the PBMs and work directly to patients. So, I think it’ll save seniors — it’ll save everybody a lot of money. Chairman: You think this is the future? Mark Cuban: Um, I don’t think it solves the ultimate problem of how the system is designed, but I think it’s something that we obviously agree on because that’s what Cost Plus Drugs is. We publish our entire price list every day. Chairman: Your company posts drug prices with full cost breakdowns. How does this transparency help save patients money? Mark Cuban: I mean, you know, with costplusdrugs.com, any patient can just go look at their price for their medication, and so there’s no uncertainty. But more importantly, by seeing our markup of only 15% and seeing our costs, that builds trust. I always tell everybody in our company that what we really sell in this industry is trust. And so I think that’s what’s really allowed us to grow so quickly. Chairman: So if you sold Ozempic and somebody else went through PBMs, how much cost would they save? Mark Cuban: Well, if you look at what’s happening now where the PBMs work with sponsors, they’re typically being charged $1,300. And if you look at the direct-to-consumer programs that are being put out there by Novo and Lilly, it’s $499 or less and probably falling. So there’s already a significant difference. And the crazy part is that difference of $800 typically goes right into the pocket of the PBM, who then decides how much they’re going to give to the employer. So it’s been — it’s a huge amount as of right now. Chairman: Thank you.